Report : Asia Pacific Brain Health Supplements Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Natural Molecules, Herbal Extract, and Vitamins and Minerals), Application (Memory Enhancement, Attention and Focus, Depression and Mood, Sleep and Recovery, Anti-Aging and Longevity, and Others), Dosage Form (Capsules, Tablets, and Others), Distribution Channel (Supermarket and Hypermarket, Drug Store, Online, and Others), and Age Category (Adults, Children, and Elderly)
At 12.5% CAGR, the Asia Pacific Brain Health Supplements Market is speculated to be worth US$ 3,049.40 million by 2028, says Business Market Insights
According to Business Market Insights’ research, the Asia Pacific brain health supplements market was valued at US$ 1,506.36 million in 2022 and is expected to reach US$ 3,049.40 million by 2028, registering a CAGR of 12.5% from 2022 to 2028. Increasing prevalence of major depressive disorders and growing demand for brain supplements among elderly population are the critical factors attributed to the Asia Pacific brain health supplements market expansion.
Depression, which is a common mental disorder, is different from normal mood fluctuations and temporary emotional responses to challenges faced every day. When depression is recurrent with moderate or severe intensity, it may become a severe health issue. It can hamper the performance of affected individuals in homes, workplaces, schools, etc. People suffering from depression are also likely to attempt suicide. Per the data published by KPMG International, the prevalence of depression is higher in Asia Pacific compared to the rest of the world, especially in the younger population. According to the National Center for Biotechnology Information (NCBI), there is growing evidence about the role of nutrients in mental health. The adequate consumption of nutrients contributes to better overall health and mental health. Hence, the optimum supply of nutrients as adjunctive therapy to antidepressant treatment is essential for adequate brain functioning. Thus, the growing prevalence of major depressive disorders is driving the growth of the Asia Pacific brain health supplements market. This is expected to drive the market during the forecast period.
On the contrary, absence of regulations and false claims by manufacturers hurdles the growth of Asia Pacific brain health supplements market.
Based on product, the Asia Pacific brain health supplements market is categorized into natural molecules, herbal extract, and vitamins and minerals. The natural molecules segment held 46.3% market share in 2022, amassing US$ 697.80 million. It is projected to garner US$ 1,385.44 million by 2028 to expand at 12.1% CAGR during 2022–2028. Further, natural molecule is segmented as acetyl-carnitine, citicoline, huperzine-A, alpha GPC, docosahexaenoic acid (DHA), and others. Additionally, herbal extract is further segmented as ginseng, curcumin, lion's mane, ginkgo biloba, bacopa monnieri, and others. Further, vitamins & minerals is further sub-segmented as vitamins C & E, vitamin B complex, and others.
Based on application, the Asia Pacific brain health supplements market is categorized into memory enhancement, attention and focus, depression and mood, sleep and recovery, anti-aging and longevity, and others. The memory enhancement segment held 33.4% market share in 2022, amassing US$ 503.18 million. It is projected to garner US$ 1,035.10 million by 2028 to expand at 12.8% CAGR during 2022–2028.
Based on dosage form, the Asia Pacific brain health supplements market is categorized into capsules, tablets, and others. The others segment held 48.0% market share in 2022, amassing US$ 722.46 million. It is projected to garner US$ 1,502.36 million by 2028 to expand at 13.0% CAGR during 2022–2028.
Based on distribution channel, the Asia Pacific brain health supplements market is categorized into supermarket and hypermarket, drug store, online, and others. The supermarket and hypermarket segment held 40.3% market share in 2022, amassing US$ 606.35 million. It is projected to garner US$ 1,243.04 million by 2028 to expand at 12.7% CAGR during 2022–2028.
Based on age category, the Asia Pacific brain health supplements market is categorized into adults, children, and elderly. The adults segment held 48.5% market share in 2022, amassing US$ 731.32 million. It is projected to garner US$ 1,525.31 million by 2028 to expand at 13.0% CAGR during 2022–2028.
Based on country, the Asia Pacific brain health supplements market has been categorized into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. Our regional analysis states that China captured 30.2% market share in 2022. It was assessed at US$ 454.69 million in 2022 and is likely to hit US$ 945.77 million by 2028, exhibiting a CAGR of 13.0% during the forecast period.
Key players dominating the Asia Pacific brain health supplements market are Danone SA; Unilever PLC; Purelife bioscience Co., Ltd.; and Harbin Pharmaceutical Group Co., Ltd., among others.
Contact Us
Contact Person: Sameer Joshi
Phone: +1- 646- 491- 9876
Email id: sam@businessmarketinsights.com